• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Small Innovators & Niche CROs

    Focus on Science

    Rapid and Data Rich Chromatographic Method Development

    Preparing Your Post Pandemic Talent Strategy

    How Modern Near-Infrared Came to Be
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Bristol Myers Squibb Expands at Cambridge Crossing

    Amgen Completes Five Prime Acquisition

    Sartorius Expands in the UK

    Obituary Notice: Russell “Russ” Haines

    Abenza Chooses North Carolina for New Biologics Manufacturing Site
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Abenza Chooses North Carolina for New Biologics Manufacturing Site

    Catalent Adds Cryogenic Capabilities at Philadelphia Facility

    Recro, Ensysce Expand Development and Manufacturing Partnership

    Metrics Names Stephanie Emory Associate Director of Pharma Development

    Albumedix Completes Commercial-Scale Mfg. Facility Expansion
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Obituary Notice: Russell “Russ” Haines

    Catalent Adds Cryogenic Capabilities at Philadelphia Facility

    Cryoport Acquires Critical Transport Solutions Australia

    PharmParts – This Makes Sense!

    Securing Your API Supply Chain: Three Keys to Success
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Bristol Myers Squibb Expands at Cambridge Crossing

    Amgen Completes Five Prime Acquisition

    Sartorius Expands in the UK

    Abenza Chooses North Carolina for New Biologics Manufacturing Site

    Arkema Recruits Dotmatics as its R&D Digitalization Partner
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Ensuring Pharma Manufacturing Quality

    What Will Change at FDA for 2021?

    RBQM Comes of Age: COVID as a Catalyst for Change

    Post-Pandemic Regulations

    Enteris BioPharma: Custom Solutions – From Bench to Market
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Syngene

    Quotient Sciences

    PCI Pharma Services

    Baxter BioPharma Solutions

    Aphena Pharma Solutions
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    PCI Pharma Services

    Syngene

    Alcami

    Baxter BioPharma Solutions

    Reed-Lane
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Features

    Traveling Toward the Intersection of Drug Development and Delivery

    Overcoming the challenges of delivering drugs to patients.

    Traveling Toward the Intersection of Drug Development and Delivery
    Related CONTENT
    • Exploring ICP-MS expertise at Almac
    • Kindeva Drug Delivery and Cambridge Healthcare Innovations Collaborate
    • Crystec Launches New R&D Center in China
    • The Ever-Evolving World of Combination Products
    • E&L Considerations for Customized Syringe Delivery Systems
    Louise Righton, Global Marketing Operations Manager, 3M Drug Delivery Systems06.12.18
    How fast are we moving toward patient-centered healthcare? In pharma, we are very cognizant of end-users whether patients or caregivers, and what our products and technologies can do to drive better outcomes for them. From a philosophical standpoint, it is simply the right thing to do. We all want the drugs, and the devices that deliver them, to address patients’ needs and solve their problems, leading to optimal outcomes. From a business standpoint, it makes perfect sense. If a product is effective, safe and also user-friendly, while offering value through better, or more cost-effective, outcomes, providers will prescribe it, payers will fund it, and patients will use it. Trust is established, and long-term value is assured. Of course, it isn’t always as easy as it sounds and a look at pharma industry statistics gives us a startling view of some of the challenges facing our drive for patient-centricity in our industry.

    The Challenges of Delivering Drugs to Patients
    The basic act of drug delivery to the patient can be beset with issues. For example, more than 65 percent of the elderly population suffers from dysphagia1 independent of the presence of any disease or illness that could directly cause the condition. Additionally, it is estimated that 25 percent of elderly people take at least three drugs.2 The majority of elderly people, therefore, may experience some difficulty swallowing, yet may also rely on a number of medications—many of them orally-delivered—to help them manage their health conditions. 

    In a similar vein, consider the case of cancer patients who suffer from nausea and vomiting brought on by chemotherapy treatment. For antiemetic drugs to treat nausea and vomiting following chemotherapy, neither a tablet nor an injectable is ideal given the usage scenario. The last thing patients undergoing chemotherapy want is another needle stick, and a patient experiencing nausea will also likely have problems with swallowing a pill—or keeping it down.

    As the population ages, many elderly patients rely on caregivers which brings its own set of challenges relative to drug delivery. Forty percent of people who enter nursing homes do so in part because they are unable to self-medicate in their own homes, and 23 percent of caregivers report problems with medication management.3 Furthermore, the average nursing home patient swallows 13 pills each day!4 With such a pill burden, alternative solutions are needed to help caregivers more easily manage medication routines, as well as give patients a more user-friendly alterative to the large number of pills they are required to swallow.

    Perhaps dialogue within the pharmaceutical community needs to shift from the perennial “how to change patient behavior,” toward modifying technology to fit the needs, behaviors and lifestyle of the patient. The mindset needs to shift from push to pull: patient education has its place but is not the be-all and end-all, and we must prioritize the pulling in of deep patient insights. An alarming number of patients suffering from asthma and chronic obstructive pulmonary disease (COPD), for example, don’t get the proper dose of their medication due to the simple fact that they are improperly using their inhalers, or not using them at all. One research report suggests that incorrect use is as high as 94 percent,5 while up to 70 percent of patients do not adhere to their prescribed therapy.6 The impact on patient outcomes—not to mention healthcare costs—is unacceptably high with failure rates like these.7 But pharma isn’t helping: there are 14 different form factors of inhalers marketed in the U.S. currently.8 No wonder patients are confused about how to use them when many are prescribed several inhalers to manage their condition. We need technologies that aren’t trying to change patient behavior, but rather are integrating with patient behavior in a more intuitive and value-added fashion. We need to understand needs, barriers, feelings, behaviors and experiences, in order to innovate for better outcomes. Patient education, long relied-upon as a tool to drive compliance, is no longer the holy grail. Striving for deep patient and caregiver insights will enable us to design drugs, delivery technologies and healthcare processes around real patient understanding—this is the new rally cry. 

    Drug Delivery as a Primary Consideration
    As we have seen, pharma has a real opportunity to make a difference, but there is a need to start the drug delivery conversation earlier. The status quo saw pharma pursuing solid-dose oral delivery if it was technically feasible, as the simplest and lowest-cost solution, irrespective of patient and caregiver needs, and practicality of the application in usage.

    When pharmaceutical companies truly examine the usage scenarios for a product and consider how to best match a delivery system with the patient profile, the solution is not always the first (often oral), or even second (injectable), choice. This realization can be daunting for pharma companies that have little to no experience with alternative delivery systems. In these situations, working with a partner that is seasoned in development and manufacturing of niche delivery methods is critical to the success of the project, and it can make the development and regulatory path much smoother. By working in partnership with drug delivery providers, pharmaceutical companies can quickly determine if an alternative delivery form is technically feasible for a drug.

    In light of the crowded and competitive pharma landscape, companies must not only deliver drugs that effectively treat patients’ illnesses but also prioritize patient experience, behavior and preference, thereby addressing compliance. By keeping patient and caregiver understanding top-of-mind during the development process, companies can commercialize delivery methods that better meet patients’ needs.

    Which Way Now?
    Global payers are ever-more demanding, and patient-centricity is one of the keys to unlock value in the future. If a patient is not compliant with prescribed medications, it can be very costly to the payer. New solutions that embrace connected technologies are an exciting recent development in drug delivery. 

    The pharmaceutical companies who embrace the new patient-centric mindset in drug design will reap rewards in the future as they drive better outcomes and establish increased trust with patients, caregivers and ultimately payers. By bringing drug development and drug delivery together early in the process, we will design pharmaceutical solutions that patients can weave naturally into their lives and which are no longer a burden to accommodate. And that’s a win for all involved. 

    References
    1. Mintel: Consumer Trends 2011-2016; Glencoe Family Health Nursing Home VOC, World Journal of Pharmaceutical Research Volume 1, Issue 3, 576-590. Review Article ISSN 2277-7105, 2004 U.S. Bureau of the Census
    2. World Health Organization; World Journal of Pharmaceutical Research Volume 1, Issue 3, 576-590. Review Article ISSN 2277-7105
    3. Cost of Care – Caregiving Facts, Frontline, PBS; Palliative Care for Older People: Better Practices, WHO 2012; China Pharmaceutical Association, 2006
    4. 3M Drug Delivery Systems Voice of Customer Research. Data on File.
    5. Lavorini et al., 2008. Respir. Med. 102(4):593-604
    6. Lindsay et al 2013; 7:329-336. doi:10.2147/PPA.S38208 and Elliott RA 2006;14(4):223-233
    7. Pritchard & Nicholls, 2015. J. Aerosol Med. Pulm. Drug Deliv. 28(2):69-81
    8. Allergy and Asthma Network

    Louise Righton is Global Marketing Operations Manager for 3M Drug Delivery Systems. Louise spent the early part of her career in the over-the-counter healthcare industry developing consumer healthcare brands in the UK, Australia, and Central & Eastern Europe. She then led the brand marketing team for the UK’s leading health and beauty retailer, before joining 3M Drug Delivery Systems in 2004 to develop its global inhaled and transdermal drug delivery technologies businesses.
    Related Searches
    • Pharma
    • pharma companies
    • china
    • Drug Delivery
    Suggested For You
    Exploring ICP-MS expertise at Almac Exploring ICP-MS expertise at Almac
    Kindeva Drug Delivery and Cambridge Healthcare Innovations Collaborate Kindeva Drug Delivery and Cambridge Healthcare Innovations Collaborate
    Crystec Launches New R&D Center in China Crystec Launches New R&D Center in China
    The Ever-Evolving World of Combination Products The Ever-Evolving World of Combination Products
    E&L Considerations for Customized Syringe Delivery Systems E&L Considerations for Customized Syringe Delivery Systems
    Eisai Begins Construction of New Injection/Research Building Eisai Begins Construction of New Injection/Research Building
    Outsourcing Solid Dosage Manufacturing Outsourcing Solid Dosage Manufacturing
    FDA Grants Tentative Approval to Generic Version of Symbicort FDA Grants Tentative Approval to Generic Version of Symbicort
    Aptamer Extends Collaboration with AstraZeneca Aptamer Extends Collaboration with AstraZeneca
    On Demand Webinar - Formulation Strategies for Poorly Soluble Molecules On Demand Webinar - Formulation Strategies for Poorly Soluble Molecules
    Injectable Drug Delivery Trends Injectable Drug Delivery Trends
    Solid Dose Market Trends Solid Dose Market Trends
    Aerosol Delivery Devices Market Aerosol Delivery Devices Market
    Evonik Strengthens Partnership with BioNTech on COVID-19 Vaccine Evonik Strengthens Partnership with BioNTech on COVID-19 Vaccine
    LipoMedix, ForDoz Enter Manufacturing Agreement LipoMedix, ForDoz Enter Manufacturing Agreement

    Related Features

    • Drug Delivery | Solid Dosage/Creams/Ointments
      Trends in Solid Oral Dosage Delivery

      Trends in Solid Oral Dosage Delivery

      Capsule demand continues to rise due to this delivery system’s versatility.
      Anita Solanki, Milind Biyani and Jnanadeva Bhat, PhD , ACG Capsules 03.01.21

    • Drug Delivery | Parenterals
      Injectable Drug Delivery Trends

      Injectable Drug Delivery Trends

      How medication trends are driving the shift to patient-friendly drug delivery systems.
      Peter Soelkner, Managing Director, Vetter 03.01.21

    • Drug Delivery | Solid Dosage/Creams/Ointments
      Oral Solids:   Market & Technology Trends

      Oral Solids: Market & Technology Trends

      Oral solids remain the preferred route of drug delivery due to their cost-effectiveness, ease of manufacturing, and patient-friendly dose form options.
      Tim Wright, Editor, Contract Pharma 03.01.21


    • Drug Delivery | Solid Dosage/Creams/Ointments
      Medicated Chewing Gum: A Modern Oral Drug Delivery System

      Medicated Chewing Gum: A Modern Oral Drug Delivery System

      Development and manufacture of medicated chewing gum continues to gain momentum.
      Rukayat Adedeji, Contributing Writer 03.01.21

    • Drug Delivery
      Inhaled Drug Delivery Technology

      Inhaled Drug Delivery Technology

      The success of any new inhaled medicine relies in a large part on the correct combination of formulation and device technology being chosen for its delivery.
      Dr. Sandy Munro, Vice President – Pharmaceutical Development, Vectura 01.27.21

    • Drug Delivery | Injectables
      Self-Medication: Flexibility for Patients and Drug Manufacturers

      Self-Medication: Flexibility for Patients and Drug Manufacturers

      Bringing together self-medication with auto-injectors and sustainable secondary packaging.
      Matthias Heinrichs, Head of Product Management and Project Engineering, Syntegon Technology 11.17.20


    • Biologics, Proteins, Vaccines | Biosimilars | Drug Development
      Biopharma Contract Manufacturing: Robust Growth Ahead

      Biopharma Contract Manufacturing: Robust Growth Ahead

      The biopharmaceutical contract manufacturing market is projected to reach $6.3 billion in 2020, and it will continue to grow over the next five years.
      William Downey, HighTech Business Decisions 11.17.20

    • Drug Delivery
      Wet Wipes Increased Prevalence in Drug Development

      Wet Wipes Increased Prevalence in Drug Development

      A number of factors including patient preference are driving the growth of wet wipes in pharma.
      John Waddell, Business Development Director – Pharma, PDI Contract Manufacturing 10.14.20

    • Drug Development | Drug Discovery | R&D
      R&D Outsourcing Trends

      R&D Outsourcing Trends

      Highly specialized drug products and capacity needs drive increased reliance on contract service providers.
      Kristin Brooks, Managing Editor, Contract Pharma 10.14.20


    • Drug Development | Preclinical Outsourcing
      Preclinical Planning for Successful Drug Development

      Preclinical Planning for Successful Drug Development

      When the preclinical pressure is on, appropriate planning can make sure timelines are achievable.
      Mingyi Trimble, WuXi AppTec 09.09.20

    • APIs | Drug Development | Risk Management
      Small-Molecule Drug Development: Advantages of an Integrated, Phase-Based Approach

      Small-Molecule Drug Development: Advantages of an Integrated, Phase-Based Approach

      Small-molecule drug development has become more complex and challenging, leading to greater reliance on CDMOs.
      Sarah Bethune, Cambrex 09.09.20

    • Biologics, Proteins, Vaccines | Drug Development | Regulatory Affairs
      Expediting a COVID-19 Vaccine: FDA Approval Process

      Expediting a COVID-19 Vaccine: FDA Approval Process

      The pressures of the pandemic are pushing sponsors and FDA to look at both efficacy and speed in developing a vaccine.
      Kristin Brooks, Managing Editor 09.09.20


    • Drug Delivery
      Not Your Father’s Oral Thin Film

      Not Your Father’s Oral Thin Film

      A look at how oral film drug delivery is evolving.
      Rodolphe Obeid, Vice President of Operations, IntelGenx 06.04.20

    • Drug Delivery | Regulatory Affairs
      Regulatory Overhaul for Medical Devices

      Regulatory Overhaul for Medical Devices

      Implications for the pharmaceutical industry.
      Elizma Parry, Director, Global Clinical Practice, Maetrics 06.04.20

    • Drug Delivery
      CEO Spotlight: Will Downie

      CEO Spotlight: Will Downie

      Vectura’s chief executive talks trends in the inhaled-drug market, and the company’s transition into a CDMO
      Tim Wright, Editor, Contract Pharma 04.01.20

    Trending
    • Thermo Fisher Acquires PPD For $17.4B
    • Ensuring Pharma Manufacturing Quality
    • Bristol Myers Squibb Expands At Cambridge Crossing
    • Abenza Chooses North Carolina For New Biologics Manufacturing Site
    • Amgen Completes Five Prime Acquisition
    Breaking News
    • Bristol Myers Squibb Expands at Cambridge Crossing
    • Amgen Completes Five Prime Acquisition
    • Sartorius Expands in the UK
    • Obituary Notice: Russell “Russ” Haines
    • Abenza Chooses North Carolina for New Biologics Manufacturing Site
    View Breaking News >
    CURRENT ISSUE

    April 2021

    • Small Innovators & Niche CROs
    • Focus on Science
    • Rapid and Data Rich Chromatographic Method Development
    • Preparing Your Post Pandemic Talent Strategy
    • How Modern Near-Infrared Came to Be
    • Securing Your API Supply Chain: Three Keys to Success
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    AstaReal Astaxanthin Ingredient Receives U.S. Patent Approval
    Study on Kemin’s DailyZz Botanical Blend Uncovers Sleep Quality, Next-Day Performance Benefits
    FDA’s Dr. Cara Welch Opening Speaker at the 9th AHPA Botanical Congress
    Coatings World

    Latest Breaking News From Coatings World

    Jebsen & Jessen, Innospec Sign Distribution Agreement
    IGL Coatings Announces Partnership in Finland
    Axalta Schedules 1Q 2021 Earnings Conference Call
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Iterative Scopes Announces IBD-Focused Scientific Advisory Board
    Vicarious Surgical, D8 Holdings Corp. Combine Operations in $1.1 Billion Deal
    FDA Grants De Novo Clearance to Medtronic’s GI Genius Model
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Bristol Myers Squibb Expands at Cambridge Crossing
    Amgen Completes Five Prime Acquisition
    Sartorius Expands in the UK
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Former L’Oréal Exec Joins Glossier
    Lancôme Reveals New Global Sustainability Program
    First-Ever Skincare Line Focuses on Iron To Prevent Aging
    Happi

    Latest Breaking News From Happi

    Fragrance Creators Association Celebrates P&G Executive
    Evonik Highlights Solutions for Malodor Reduction
    P&G Emphasizes Small Actions at Home To Be More Sustainable
    Ink World

    Latest Breaking News From Ink World

    Kumon North America Adds Speedmaster XL 106 from Heidelberg
    SE-DA Invests in Kornit Presto S
    Acrylic Resins Market Worth $21.9 Billion by 2025: MarketsandMarkets
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    TLMI reveals Eugene Singer Award winners at Virtual Spring Summit
    Monadnock Paper Mills joins SGP
    ACTEGA helps converter reach sustainability goals
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Albaad to Add Natural-Based Line in Israel
    First Quality to Discontinue Tampon Operations
    Jessup Installs New Era Coating and Laminating Line
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    BioMagnetic Sciences Names President and CEO
    Mainstay Medical Launches ReActiv8 in Australia
    Biogennix Rolls Out Agilon Strip Bone Graft
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Virtual ASMC 2021 Spotlights Advanced Semiconductor Manufacturing Excellence
    LG Display Cuts Down CO2-eq Emissions by 3 Million Tons in 2020
    European Commission's Innovation Radar Acknowledges 3 ARMOR Innovations

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login